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Abstract
Deviation from proper muscle development or homeostasis results in various myopathic conditions. Employing genetic as
well as chemical intervention, we provide evidence that a tight regulation of Wnt/b-catenin signaling is essential for muscle
fiber growth and maintenance. In zebrafish embryos, gain-of-Wnt/b-catenin function results in unscheduled muscle
progenitor proliferation, leading to slow and fast muscle hypertrophy accompanied by fast muscle degeneration. The
effects of Wnt/b-catenin signaling on fast muscle hypertrophy were rescued by misexpression of Myostatin or p21
CIP/WAF,
establishing an in vivo regulation of myofibrillogenesis by Wnt/b-catenin signaling and Myostatin. Epistatic analyses suggest
a possible genetic interaction between Wnt/b-catenin and Myostatin in regulation of slow and fast twitch muscle
myofibrillogenesis.
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Introduction
Understanding muscle development is crucial for generating
novel regenerative therapies for muscle diseases and treating
muscle injuries. Extensive research has contributed to the current
understanding of various aspects of somitogenesis and myogenesis.
The periodicity of rostral-caudal somite formation [1] as well as
their differentiation into the axial skeleton, skeletal muscle and
dorsal dermis are similar in all vertebrates [2]. Furthermore, the
zebrafish determinate muscle growth by hyperplasia, the increase
in muscle fiber number, and by hypertrophy, the increase in
muscle fiber size, are comparable to mammalian muscle growth
making it a suitable model system to study myofibrillogenesis and
various myopathies [3–5].
Wnt/b-catenin pathway plays a crucial role in early somitogen-
esis and myogenesis in birds [6,7], mice [8–10] as well as in
zebrafish [11] by affecting skeletal muscle development at several
levels, including mesodermal patterning, segmentation clock and
myoblast differentiation [12,13]. The Wnt/b-catenin signaling
regulates Lef/Tcf–mediated transcription of downstream target
genes via the transcriptional coactivator b-catenin [14]. In the
absence of Wnt ligand, b-catenin is targeted for proteosomal
degradation by a ‘‘destruction complex’’ comprising of CK1,
GSK3b, Axin1 and Apc1. The fine balance between proliferation
and differentiation required for proper development and growth of
the myotome depends on signaling cues originating from tissues
surrounding the somites [15,16], including Wnt ligands. Cumu-
lative evidence implicates Hedgehog and Fgf8 signaling in
specification and differentiation of slow and fast twitch muscle
fibers respectively, during the first wave of myogenesis [17–20].
Although recent work has shown the role of Hedgehog signaling in
differentiation of a subset of secondary slow twitch muscle fibers
[19], the precise molecular mechanism underlying specification
and maintenance of secondary fast twitch muscle fibers as well as
the Hedgehog independent slow twitch muscle fibers remains to be
elucidated.
This study shows that upward deviation from the tightly
controlled physiological level of Wnt/b-catenin activity by genetic
and chemical intervention in zebrafish embryos leads to
compromised growth and maintenance of slow and fast muscle
fibers. This phenotype derives from hyperproliferation of the
Pax3/7+ pre-myogenic precursors. Hence, misexpression of
p21
CIP/WAF or mstn in the embryos with gain-of-Wnt/b-catenin
function restores the integrity as well as morphology of the fast
muscle fibers. We further discuss the possibility that this tight and
opposing regulation of myofibrillogenesis by Wnt/b-catenin and
Myostatin in zebrafish could operate through their genetic
interaction.
Results
Wnt/b-catenin hyperactivity causes loss of somites and
aberrant muscle fibers
Wnt/b-catenin gradient has been shown to be important for
somite segmentation [9]. Importantly, it has been suggested that
Wnt/b-catenin is downregulated in the somite following skeletal
muscle differentiation [21]. We investigated the expression of
Wnt/b-catenin reporter TOPdGFP [22] during post-segmenta-
tion corresponding to the second wave of myogenesis. Consistent
with previous studies [21], we observed only faint expression in the
trunk and tail of wild-types at 28 hours post-fertilization (hpf)
(Fig. 1A). Next, by employing the homozygous compound
zebrafish mutants of axin1 [23,24] and apc1 [25] (hereafter referred
to as axin1/apc1), we investigated whether Wnt/b-catenin is
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5880Figure 1. Hyperactivation of Wnt/b-catenin pathway leads to late somite-loss. (A) TOPdGFP transgenic embryos report activated Wnt/b-
catenin signaling, i.e. TOPdGFP transcripts. Cartoon depicts the level of vibratome sectioning i.e. left panel at the yolk extension and right panel
caudal to the yolk extension. Scale bar, 50 mm. (B) Hyperactivation of a target of Wnt/b-catenin pathway lef1, as shown with WISH, in axin1/apc1
mutants matches the expression of TOPdGFP. Scale bar, 250 mm. (C) The axin1/apc1 embryos are slightly shorter compared to wild-type embryos at
36 hpf, top panels. At 54 hpf, the difference becomes striking, bottom panels. Scale bar, 500 mm. (D) Somite counts at 36 hpf and 54 hpf,
corresponding to embryos depicted in (C) with error bars showing the standard deviation.
doi:10.1371/journal.pone.0005880.g001
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expression of the TOPdGFP reporter in axin1/apc1 mutants in a
rostro-caudally rising gradient (Fig. 1A). This corresponded to
enhanced expression of the Wnt transcription factor and its direct
target gene lef1 [26] throughout the somites (Fig. 1B), showing that
Wnt pathway is overactivated in the somites of axin1/apc1 mutants.
At completion of segmentation and the first wave of myogenesis
at 24 hpf, axin1/apc1 embryos had a normal number of somites,
size of somites (Fig. S1), as well as normal muscle fiber formation
(data not shown). The earliest clear somite phenotype in axin1/
apc1 mutants was at 36 hpf, with a slight decrease in somite
number from approximately 31 to 29 (Fig. 1, C and D). Strikingly,
at 54 hpf, there was a severe tail truncation due to loss of
approximately 10 somites (Fig. 1, C and D). The formation of
normal somites at 24 hpf (Fig. S1) eliminates somite fusion and
abnormal initiation of segmentation as an underlying cause of
somite loss. Hence, this late and gradual somite-loss strongly
suggests that the underlying mechanism does not entail a defect in
somite induction and/or patterning.
Next, we examined whether upregulation of the Wnt/b-catenin
signaling would affect the fast- and slow-twitch muscles that make
up the myotome. The slow muscle fibers appeared to be
hypertrophic, as well as hyperplastic with an additional 2–4 fibers
per somite (n=4) (Fig. 2A). Strikingly, the fast muscle fibers were
disorganized, with some muscle fibers detaching from the vertical
myoseptum, forming small lesions, while becoming hypertrophic
only at 54 hpf (Fig. 2A). Confirming the distinct effects of
hyperactive Wnt/b-catenin on slow versus fast muscle fibers,
quantification by RT-qPCR of myosin heavy chain specific for
slow or fast twitch muscle fibers revealed an increase in fast muscle
myosin at 54 hpf (Fig. 2B). However, there is no significant
difference observed for slow muscle myosin (Fig. 2B).
We confirmed the specific role of Wnt/b-catenin by employing
a chemical activator of the Wnt/b-catenin pathway, lithium
chloride (LiCl). The wild-type embryos treated with LiCl prior to
completion of somitogenesis, at tailbud and mid-somitogenesis
were truncated and curled albeit no detached muscle fibers were
present (Fig. 2C, early treatment). In contrast, the embryos treated
after 24 hpf showed severe muscle fiber detachment and
hypertrophy (Fig. 2C, mid-treatment and late-treatment), resem-
bling axin1/apc1 mutants. Hence, the muscle fiber defect in the
axin1/apc1 mutants is likely also caused by late Wnt/b-catenin
hyperactivation.
The fast muscle fiber degeneration beginning at 36 hpf,
corresponded with gradual increase in apoptosis (Fig. 3A), with
apoptosis occurring within the myotome (Fig. 3B) and along the
vertical myoseptum (Fig. 3, A and C).
Hyperactive Wnt/b-catenin drives muscle progenitors
into unscheduled proliferation
The ability of Wnts to enhance proliferation in the dermomyo-
tome [27] led us to hypothesize that unscheduled proliferation in
the somites might lead to muscle hypertrophy in axin1/apc1
mutants. While at 16 hpf there was no difference in proliferation
between mutants and wildtypes (data not shown), from 28 hpf
onwards, BrdU pulse experiments identified a sharp increase in
number of cells in S-phase (Fig. 4A), which was confirmed by
increased labeling of phosphohistone H3 (PH 3)+ mitotic cells
(data not shown) and their quantification by FACS (Fig. S2B). To
investigate whether this unscheduled increased proliferation
caused muscle hypertrophy, we partially inhibited cell division
with a combination of aphidicolin [28] and hydroxyurea (HUA)
[29] from 24 hpf until fixation at 54 hpf. Strikingly, the fast muscle
hypertrophy (Fig. 4B; compare to Fig. 2A, right panels) and
degeneration (Fig. S3A) as well as the number of somites were
partially rescued (Fig. 4B) confirming that hyperproliferation leads
to the fast muscle hypertrophy and degeneration.
Pre-myogenic embryonic muscle progenitor cells expressing
Pax3/7 transcription factors give rise to myoD+ myoblasts,
myogenin+ myocytes and myotubes, that terminally differentiate
into muscle fibers [30]. To determine whether these Pax3/7+
progenitors were stimulated by Wnt/b-catenin to hyper-prolifer-
ate, we performed co-labeling of PH 3 and Pax3/7 in the axin1/
apc1 mutants. There was a significant increase in co-localization of
PH 3+ mitotic nuclei and Pax3/7+ nuclei in the axin1/apc1
mutants (Fig. 4C) as compared to wild-types, suggesting that Wnt/
b-catenin drives unscheduled proliferation of pre-myogenic
progenitors. Surprisingly, the absolute number of Pax3/7+ cells
was unaltered in axin1/apc1 mutants (data not shown), suggesting
that the newly born progeny of dividing Pax3/7+ cells was not
maintained in a Pax3/7+ precursor state, but instead was
instructed to differentiate. Hence, we examined myogenic
differentiation in the mutants. Consistent with the unperturbed
Pax3/7+ muscle progenitors at 16 hpf, myoD was unaltered in
axin1/apc1 mutants during initial myogenesis (data not shown).
Importantly, later in development, its timely downregulation failed
and its expression was sustained (Fig. S3B). Consistent with
prolonged myoD expression in mutants, myogenin expression was
also extended in axin1/apc1 (Fig. S3C). As myoD+ myoblasts are
known to proliferate it is possible that the ectopic and extended
myoblast maintenance also contributes to the hyperproliferation in
the mutants. To test this, we performed co-labeling of anti-MyoD
with anti-BrdU antibody (with BrdU incorporation chased for
2 hours). We observed substantial increase in MyoD+ cells in
axin1/apc1 embryos (Fig. S3D), confirming the increased myoD
RNA expression in the mutants. However, we do not observe an
increase in proliferating (BrdU+) myoD+ cells (data not shown).
The data is consistent with a positive role of Wnt/b-catenin
signaling in driving myogenic differentiation [13].
Myotomal proliferation and hypertrophy in axin/apc
mutants are counteracted by misexpression of Mstn and
its downstream target p21
CIP/WAF
Reportedly, Wnt/b-catenin through its direct target c-myc, can
downregulate p21
CIP/WAF (also known as cyclin-dependent kinase
inhibitor 1A) [31]. We hypothesized that sustained myotomal
proliferation in axin1/apc1 mutants works through Wnt/b-catenin-
mediated inhibition of p21
CIP/WAF. We tested the hypothesis by
examining the capacity of p21
CIP/WAF mRNA injected into axin1/
apc1 mutant to rescue muscle fiber phenotype. Employing
misexpression with p21
CIP/WAF mRNA concentration that only
subtly affected the wildtypes, muscle fiber hypertrophy was
rescued in injected axin1/apc1 embryos (Fig. 5A), suggesting that
muscle fiber degeneration is due to hyperproliferation caused by
failure of timely p21
CIP/WAF-dependent cell cycle exit. However,
we cannot exclude the possibility that forced cell cycle exit
mediated by p21
CIP/WAF misexpression in itself, and independently
of its postulated positioning downstream of the Wnt pathway, may
have brought about the rescue.
p21
CIP/WAF has been implicated in muscle differentiation as the
downstream target of Mstn, a TGF-b family member. Mstn is a key
negative regulator of muscle growth that promotes terminal
differentiation of embryonic muscle progenitors through the
activation of p21
CIP/WAF [32]. Decreased levels of Mstn, context
dependently lead to muscle hypertrophy [32]. Based on the
hypertrophic muscle phenotype in the compound mutants and
upon late LiCl treatment of wildtype embryos, we hypothesize that
p21
CIP/WAF may be epistatic to Mstn and that overactive Wnt
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PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5880Figure 2. Late hyperactivation of Wnt/b-catenin pathway leads to aberrant myofibrillogenesis. (A) axin/apc1 embryos at 36 hpf have
thickened slow muscle fibers, left panels. The fast muscle fibers at 36 hpf are detached from the vertical myoseptum, forming lesions (white arrow
heads) and are disorganized, middle panels. At 54 hpf, fast muscle fibers are thickened (hypertrophic), right panels. All embryos were imaged at the
positions as depicted in cartoons. Images for F59 and Eb165 at 36 hpf are cumulative z-stacks. Images for Phalloidin at 54 hpf are single z-plane at the
level of fast muscle fibers. Scale bar, 25 mm. (B) Quantitative real-time PCR (qRT-PCR) of myhz2 (fast muscle specific) and myhz5 (slow muscle specific)
mRNA expression normalized to actin. Graphs show that the quantity of myhz5 is not significantly different in axin1/apc1 embryos, failing to identify
subtle difference as shown in Fig. 2A. The quantity of myhz2 is upregulated in axin1/apc1 embryos at 54 hpf. (C) LiCl treatment during various time
intervals. Early treatment=tailbud stage and 16 hpf for 40 minutes each on the same clutch of embryos, mid treatment=at 16 hpf and 24 hpf and
late treatment=at 24 hpf and 30 hpf. Embryos were stained with Phalloidin for visualization of all muscle fibers. All embryos were imaged at the level
of the yolk extension, as depicted in cartoon. Images are cumulative z-stacks. Scale bar, 25 mm.
doi:10.1371/journal.pone.0005880.g002
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CIP/WAF.
We tested this possibility by performing rescue of muscle fiber
degeneration in the axin1/apc1 mutants via misexpression of mstn
mRNA. While at this particular concentration of mstn, wild-types
showed slightly hypotrophic muscle fibers, the axin1/apc1 embryos
showed a partial rescue of the hypertrophic muscle fibers (Fig. 5A).
Consistently, misexpression of mstn rescued the number of somites
(n=8) and length of mutant embryos (Fig. 5, B and C). Importantly,
cell survival in axin1/apc1 mutants was also rescued (Fig. 5C, right
panels).
To further explore opposing effects of Wnt/b-catenin and
Myostatin on phenotypic aspects of myofibrillogenesis we asked
whether morpholino (MO)-mediated knock-down of Mstn would
result in a similar hypertrophic phenotype as hyperactive Wnt/b-
catenin in zebrafish embryos. Injection of 5 ng mstn MO resulted
in hypertrophic muscle fibers, while injection of 2 ng Lef1 MO
Figure 3. Apoptosis at somite boundaries and muscle fibers. (A) From 36 hpf onwards, axin1/apc1 embryos show an increase in apoptosis as
labeled by TUNEL. Insets show the imaged area. Scale bar, 100 mm. Apoptotic cells labeled with acridine orange lining up at the somites boundaries,
right panel. Arrows and lines mark the somite boundaries. Scale bar, 25 mm. (B) TUNEL labeling at 54 hpf show an increase in apoptotic cells in the
myotome. Cartoon depicts the level of sectioning i.e. left panel at the posterior end of the yolk extension and right panel posterior end of the tail. NT-
neural tube; M-myotome. (C) Co-labeling of fluorescent TUNEL assay (apoptotic cells) and phalloidin labeling (muscle fibers), left and middle panel.
This CLSM image was taken caudal to the yolk extension, at a single z-plane of 5 mm of fast muscle fibers.
doi:10.1371/journal.pone.0005880.g003
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injected 2 ng Lef1 MO with 10 ng Mstn MO, and asked whether
muscle fibers would be hypertrophic or hypotrophic. The slow and
fast muscle fibers appear hypertrophic (Fig. 6). As a loss of Mstn
signaling would be expected to lead to hyperproliferation, and loss
of Wnt/b-catenin signaling to reduction of proliferation of pre-
myogenic precursors, the data suggests that loss of Mstn is
dominant over the loss of Wnt/b-catenin signaling.
As expression profiling in Mstn loss-of-function (LOF) identified
modulation of Wnt- pathway components [33], we examined for
possible genetic interaction between the two pathways, by using
gain and loss of Wnt/b-catenin signaling. To establish a suitable
genetic means for analysis of mstn mRNA upon loss of Wnt/b-
catenin function, we first tested whether morpholino (MO)-
mediated knock-down of Lef1 [22], which is upregulated in
axin1/apc1 mutants (Fig. 1B) would rescue their aberrant
somitogenesis. Knockdown of Lef1 with 2 ng MO in wild-types
resulted in loss of a number of somites (59%, n=54) at 54 hpf
(Fig. 7A), suggesting that Lef1 is required for normal somitogen-
esis. Notably, in 50% of Lef1-MO-injected axin1/apc1 mutants, the
normal number of somites was restored, establishing a mechanistic
link between Lef1 hyperactivity and somite loss (Fig. 7A).
Figure 4. Myotome hyperproliferation and sustained differentiation in axin/apc1 embryos. (A) BrdU pulse was performed at 36 hpf,
chased for 12 hours, and imaged at 48 hpf. Embryos were imaged at the level of the yolk extension. Scale bar, 25 mm. BrdU+ pulse was performed at
28 hpf or 36 hpf, and quantification of number of BrdU+ proliferating cells per somite was done 12 hours later at 40 hpf or 48 hpf, respectively. (C)
HUA treatment of embryos from 24 hpf until fixation at 54 hpf. Inhibition of proliferation with HUA from 24 hpf results in rescue of muscle
hypertrophy. Muscle fibers were stained with Phalloidin, and imaged at 54 hpf at the level of the yolk extension. Compare with untreated wild-types
in Fig. 2A (right panels). Scale bar, 25 mm. Quantification of number of somites is increased in axin1/apc1 mutants upon HUA treatment. (E)
Colocalization of Pax3/7+ and PH 3+ cells shows proliferating muscle progenitors. Quantification of proliferating Pax3/7+ and Pax3/7- cells in the
wild-types vs. axin1/apc1 mutant embryos shows significantly more proliferating Pax3/7+ cells in the mutants. Scale bar, 50 mm.
doi:10.1371/journal.pone.0005880.g004
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affected the levels of mstn RNA, we employed quantitative real-time
PCR to quantify expression of mstn mRNA in axin1/apc1 mutants
versus Lef1-morphants at different developmental times. The data
showed that reduced Wnt/b-catenin signaling in Lef1 morphants
resulted in upregulation of mstn mRNA (Fig. 7B, C), whereas
hyperactivityofthepathway inthe axin1/apc1mutants led toa slight
mstn downregulation at 36 hpf (Fig. 7B), and a more significant
downregulation at 54 hpf (Fig. 7C). We then analyzed the level of
Myostatin protein at 54 hpf. Predictably and in agreement with the
qPCR data, the level of processed mature monomeric Myostatin
protein was significantly induced in Lef1-morphants suggesting that
reduced Wnt signaling through Lef1 leads to de-repression of
Myostatin. Surprisingly, in axin1/apc1 embryos, the level of
Myostatin protein is similar to that of wild-type embryos, suggesting
that subtle increase of myostatin mRNA in the Wnt/b-catenin GOF
context, does not translate into an increase in the stable protein
(Fig. 7D). Why and how this mechanistically takes place need
further investigation. As lef1 was upregulated in the somites of axin/
apc mutants at 30 hpf, we tested whether misexpression of mstn
would alter this Wnt/b-catenin downstream target gene. Misex-
pression of mstn downregulated ectopic lef1 in the mutants as well as
slightly downregulating lef1 expression in wildtype siblings (Fig. 7E)
showing genetic interaction between Mstn and Wnt/b-catenin
signalling and probably underlying the mechanism of muscle fiber
rescue. To corroborate possible interaction between the two
pathways we performed in silico analysis to identify putative TCF-
binding elements (TBE) in myostatin promoter, as have been
identified in the promoters of Wnt target genes [34]. Indeed, we
found 3 putative TBE (NNCAAAG) within a 2.8 kb sequence
upstream of the myostatin gene at positions -2790, -2389 and -1578
(data not shown) opening up the possibility of a direct interaction
between Wnt and Myostatin.
Together, these data suggest an existence of a genetic
interaction between Wnt/b-catenin and Mstn in myofibrillogen-
esis possibly existing as a negative feedback loop. We propose a
model describing regulation of fast muscle fiber growth and
maintenance during secondary myofibrillogenesis with respect to
Mstn and Wnt signaling (Fig. S4).
Discussion
Most zebrafish mutants such as after eight (aei) and deadly seven
(des) that harbor mutations in genes of the Delta-Notch pathway
[35] display a reduction in somite numbers secondary to
patterning. Together with Delta-Notch signaling, Wnt/b-catenin
signaling contributes to somite clock establishment, mediating
early somite patterning [36,37]. The unique phenotype of the
axin1/apc1 mutant is characterized by normal somite patterning
followed by a gradual loss of approximately 10 most caudal
somites. Our data show that this somite loss, resulting from
sustained, ectopic and hyperactive Wnt/b-catenin, is secondary to
cell fate alterations, ultimately leading to hypertrophic and
degenerative fast muscle fibers. The hyperactive Wnt signal is
transduced mainly through Lef1 and leads to an imbalance
between proliferation and differentiation in the myotome. The late
activation of Wnt/b-catenin in wild-type embryos by treatment
with LiCl phenocopies the fast muscle fiber hypertrophy and
degeneration observed in axin1/apc1 embryos. This corroborates
the notion that the mutant muscle fiber phenotype arises
independently and is subsequent to normal somite establishment,
providing an opportunity to decouple roles of Wnt/b-catenin in
myofibrillogenesis versus somite patterning.
High Wnt/b-catenin activity is required for somite patterning,
as well as for proliferation i.e. expansion of the Pax3/7+ pre-
myogenic progenitor compartment. Pax3 and Pax7 transcription
factors, that mark the pre-myogenic progenitors in the developing
dermomyotome [38] and satellite cells in the adult muscle,
Figure 5. Misexpression of mstn rescues axin1/apc1 embryos. (A)
Injection of 5 pg p21
CIP/WAF or mstn mRNA into 1 cell stage embryos,
and phenotype assessment at 54 hpf. Slightly hypotrophic muscle
fibers are observed in p21 as well as mstn-injected wild-type embryos
confirming efficiency of misexpression. Muscle hypertrophy in mstn-
injected axin1/apc1 embryos is partially restored to normal. (B)
Quantification of the somite number of uninjected and p21
CIP/WAF or
mstn mRNA (5 pg) injected embryos. (C) Misexpression of mstn partially
restores the truncated somite phenotype, as well as cell survival in
axin1/apc1. Scale bar, 0.5 mm.
doi:10.1371/journal.pone.0005880.g005
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been implicated in induction of Pax3/7+ precursors in cell culture
systems [41,42]. A high Wnt/b-catenin activity is probably also
required for proliferation of differentiating myoblasts. Our data
suggest that the sustained upregulation of myoD and myogenin in
axin1/apc1 reflects propensity towards differentiation of hyperpro-
liferating pre-myogenic Pax3/7+ precursors being consistent with
the known role of Wnt/b-catenin signaling in myogenic
differentiation in several systems [43,44].
We show that hyperproliferative fast muscle fibers underlie the
fast muscle fiber degeneration in the axin1/apc1 mutants, as partial
inhibition of proliferation restored to near normal impaired cell
survival and fast muscle fiber hypertrophy. The hypertrophic
muscle fibers in axin1/apc1 embryos indicate that a myotomal cell
population(s) hyperproliferates and differentiates, thus resulting in
an increase in the mass of the muscle fiber. Simultaneously,
conflicting instructions to myoblasts to undergo premature
differentiation likely leads to apoptosis. To our knowledge, Wnt/
b-catenin has as yet not been implicated in muscle hypertrophy in
vivo. Ex vivo studies of the adult muscle reveal the synergistic effect of
insulin and Wnt/b-catenin in causing myotube hypertrophy [45].
In addition, it has been shown that Wnt/b-catenin is upregulated in
overload-induced hypertrophy of the adult muscle [46]. As a
conserved transcriptional hierarchy is thought to regulate the
myogenic differentiation in embryos and adults [47], these reported
data may be extrapolated to the developing myotome.
Several in vitro and in vivo studies showed that Mstn
overexpression prevents proliferation and differentiation of muscle
precursors by inducing expression of the cell cycle inhibitor
p21
CIP/WAF, while endowing muscle progenitors with competence
to respond to signals favoring muscle differentiation [32]. We
showed that simultaneous knockdown of Lef1 and Myostatin,
resulted in a hypertrophied muscle fiber, similar to knockdown of
Myostatin. This suggests that Wnt/b-catenin signaling could lie
upstream of the Mstn regulatory pathway, as knockdown of Lef1 is
unable to rescue the myofiber phenotype (Fig. 6), while
misexpression of mstn partially rescues the fast muscle hypertrophy
in axin1/apc1 embryos (Fig. 5A). Thus, Wnt/b-catenin might
mediate sustained proliferation of muscle progenitors by repressing
mstn. However, there is also the possibility that the rescue of
myofiber growth is non-specific and Myostatin might work
independently of and/or in parallel with Wnt/b-catenin signaling
in regulating myoblasts proliferation and differentiation. We favor
the possibility of a Wnt/b-catenin-Mstn negative feedback loop, as
our experimental evidence points towards a specific interaction,
direct or indirect, between Wnt/b-catenin signaling and Myostatin
as follows: (1) We observe an upregulation of mstn RNA transcripts
and protein upon Lef1 knock-down which may reflect release from
repression of mstn by Wnt/b-catenin (2) The downregulation of lef1
mRNA expression upon mstn misexpression in axin1/apc1 and
wildtype embryos suggests a negative feedback loop between Wnt/
b-catenin and mstn, likely reflecting the mechanism that underlies
phenotype-rescuing capacity of Lef1; (3) The identification of 3
putative TBE within a 2.8 kb region upstream of the Myostatin
ATG start site opens up a possibility of a molecular interaction
between Mstn and Wnt/b-catenin signaling. However, Wnt/b-
catenin could also mediate repression of Mstn indirectly, through
induction of its direct target follistatin [48] that is a known
negative regulator of Mstn [49]. Whether and how this genetic
hierarchy regulating myofibrillogenesis translates into direct
molecular interactions is an important avenue for further research.
Unlike mice expressing dominant negative Mstn, which equally
affects both fast and slow muscle fibers, the axin1/apc1 embryo
exhibits different phenotypes with both slow and fast muscle fibers.
Although hypertrophy and hyperplasia is observed in the slow
muscle fibers at 36 hpf, there is a reduction in the total amount of
slow muscle myosin RNA. We speculate that the lack of
quantitative differences observed in the slow muscle fibers could
be due to the fact that slow muscle fibers only make up a small
portion of the myotome. Therefore, a small increase of slow
Figure 6. Mstn is dominant over Wnt/b-catenin in myofibrillogenesis. Representative images of injection of 5 ng (n=30) or 10 ng (n=30)
Mstn MO results in muscle hypertrophy, whereas injection of 2 ng Lef1 MO (n=30) results in hypotrophic muscle fibers. Co-injection of 10 ng Mstn
MO with 2 ng Lef1 MO (n=10) results in hypertrophic muscle fibers. Images of all embryos are cumulative z-stacks and taken at the level of the yolk
extension, as depicted in cartoons. Scale bar, 50 mm.
doi:10.1371/journal.pone.0005880.g006
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fast muscle fibers exhibit muscle fiber degeneration and disorga-
nization at 36 hpf, and at 54 hpf, they appear hypertrophic
(Fig. 2A). This is confirmed by a significant increase of the total
amount of fast muscle myosin at 54 hpf (Fig. 2B). The fast muscle
hypertrophy is likely to reflect a compensatory response to
decreased muscle stability. Significantly, it is only the fast muscle
fibers that degenerate in response to hyperactive Wnt/b-catenin
signaling even prior to overt hypertrophy. In agreement to the
upregulation of fast muscle myosin in axin1/apc1 embryos, it has
recently been shown in cattle that knock-out mutations in
myostatin result in preferential downregulation of fast 26myosin
heavy chain [50]. Consistently, mstn, which we showed is affected
by Wnt/b-catenin pathway is predominantly found in fast twitch
muscle [51]. This study opens up a prospect to unravel the poorly
understood difference in regulation of maintenance and growth of
secondary slow versus fast muscle fibers.
Although our work showed that Mstn negatively regulates Wnt/
b-catenin, it is very likely that there is an involvement of other
signals that mediate timely and dosage-regulated restriction of the
Wnt/b-catenin pathway, thereby safeguarding myofibrillogenesis
and regulated muscle growth. The pathogenetic mechanism of the
muscle hypertrophy in muscle degenerative diseases is still unclear.
Our data, implicating a possible role of Wnt/b-catenin signaling in
interaction with Mstn and p21
CIP/WAF, which have been shown to
be important in muscle diseases, might pave a way to approaching
muscle diseases from a novel angle.
Materials and Methods
Zebrafish embryos
Zebrafish embryos were raised and staged as previously
described[52]. apc
CA50a/CA50a is a lethal recessive zygotic mutation
identified in a three generation forward mutagenesis screen [25]
Figure 7. mstn is upregulated in LOF Wnt/b-catenin. (A) 2 ng Lef1 MO was injected at 1-cell stage into wild-type or axin1/apc1 embryos, and
the number of somites was counted at 54 hpf. Two independent clutches of axin1/apc1 heterozygous incross were analyzed (Total n=64), in which
10 were genotyped as axin1/apc1 homozygous. (B) Quantitative real-time PCR (qRT-PCR) of myostatin mRNA expression normalized to actin. Total
RNA was isolated from 36 hpf wild-type, axin1/apc1 and Lef1 morphant embryos. Graphs show that expression of mstn is upregulated in Lef1
morphants, corresponding to the in situ hybridization with mstn probe in bottom panels. Scale bar, 100 mm. (C) Quantitative real-time PCR (qRT-PCR)
of myostatin mRNA expression normalized to actin. Total RNA was isolated from 54 hpf wild-type, axin1/apc1 and Lef1 morphant embryos. Graphs
show that expression of mstn is downregulated in axin1/apc1 embryos and upregulated in Lef1 morphants (D) Western blot on lysates collected from
54 hpf wild-type, axin1/apc1 and Lef1 morphant embryos. Graph shows upregulation of Mstn in Lef1 morphants. However, there is no significant
difference in levels of Mstn protein in axin1/apc1 embryos versus wildtypes. (E) Misexpression of mstn mRNA downregulates the Wnt target gene lef1
in axin1/apc1 mutants shown with WISH for lef1 riboprobe. Scale bar, 100 mm.
doi:10.1371/journal.pone.0005880.g007
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recessive lethal zygotic mutant obtained in the large scale
Tubingen screen[24]. axin1/apc1 compound mutants were gener-
ated from crossing apc
CA50a/CA50a with axin/mbl(tm13).
Fish/embryo genotyping
To verify phenotype/genotype correspondence, nested PCR was
performed to amplify the template. First amplification was done
using outer primer pair apc1forward(1)-apc1reverse(4) for identifi-
cation of apc1 mutants, and outer primer pair axin1forwards(1)-
axin1reverse(4) for identification of axin1 mutants. Second ampli-
fication for apc1 and axin1 was done using primer pair apc1for-
ward(2)-apc1reverse(3) and primer pair axin1forward(2)-axin1re-
verse(3) respectively. Primer sequences are as follows:
apc1forward(1) 59-GTGCCTTAGAGGTGCAGAAG-39, apc1for-
ward(2) 59-GCAGTGTCCTTGTGGTTATG-39, apc1reverse(3)
59-TGCCTTTACACATTGGTGAG-39, apc1reverse(4) 59-CAC-
AATCCTAACAAGCCATTC-39, axin1forward(1) 59-ATGTGT-
CCTCCATTTGTCTG-39, axin1forward(2) 59-TTTGTCTGTC-
CACATACCTG-39, axin1reverse(3) 59-ACACCAGGAAATTC-
ATCCAG-39, axin1reverse(4) 59-GATGCTCCTTCATTCCAA-
AC-39. DNA sequencing was performed using apc1forward(2) and
axin1forward(2) to identify the specific genetic mutations as
described previously [24,25].
In situ hybridization and immunohistochemistry
Whole-mount in situ mRNA hybridization (WISH) was carried
out as previously described[53]. Embryos were fixed in 4%
paraformaldehyde (PFA) overnight at 4uC and digoxigenin-tagged
probes were made with Roche labeling mix to TOPdGFP, myoD,
myogenin, lef1, and titin. For mstn, exonic fragments were generated
with the primers: T3mstn(f) 59-ATTAACCCTCACTAAAGGGA-
GAATGAACATGCCACCACAGAA-39 and T7mstn(r) 59-TAA-
TACGACTCACTATAGGGAGATAATCCAGTCCCAGCCA-
AAG-39, and digoxigenin-tagged probes were made. Embryos were
fixed for antibody staining with 4% PFA or Carnoy’s and whole-
mount immunohistochemistry was performed according to Du et al.
[54], using primary antibodies A4.1025 (Developmental Studies
Hybridoma Bank) 1:20, Eb165 (Developmental Studies Hybridoma
Bank) 1:250, Pax3/7 1:20 (gift from Prof. N. Patel), PH 3 (Upstate
Biotechnology #06570) 1:1000, MyoD 1:250 (Santa Cruz, C-20,
sc-302). Appropriate secondary antibodies were used at 1:200.
Immunohistochemistry was analyzed at the level of yolk extension
where there is minimal muscle degeneration, unless otherwise
stated, as caudal to the yolk extension there is massive apoptosis.
Phalloidin staining
Phalloidin-TRITC (Sigma) staining (1:50) was performed at
room temperature overnight. Muscle fibers were analyzed at the
level of the yolk extension where there is minimal muscle
degeneration, as caudal to the yolk extension there is massive
apoptosis.
Microinjection of mRNAs and morpholinos (MO)
Morpholino antisense oligonucleotides were obtained from
Gene Tool (Philomath, OR): zflef1 (ATG) 59-CTCCTCCACCT-
GACAACTGCGGCAT-39 [22] and zMstn (ATG) 59-
TGCATGTTCCAAGGCGTGCTAAAGG-39. We validated ef-
fectiveness of Mstn morpholino by showing its capacity to knock-
down the protein (Fig. 7D). Capped synthetic mRNA was
prepared from pCS2+ constructs encoding zebrafish mstn (gift
from L.D. Valle) or human p21
CIP/WAF (gift from C.J. Weijer)
using the mMessage mMachine kit (Ambion), and injected into
one-cell stage embryos using a microinjector (World Precision
Instruments). A concentration range of 2.5–100 pg of mRNA was
injected into one-cell stage embryos to test for viability and effect,
and the concentration which had only a subtle effect on wild-type
embryos was selected. For axin1/apc1 rescue experiments, 5 pg of
mstn or p21
CIP/WAF mRNA was used.
Cell quantification and imaging
Fluorescent labelings were imaged using a Leica TCS SPE
confocal microscope. For each set of experiments, all laser and
software settings were standardized. Images from each embryo
were cropped in Volocity (Improvision) to exclude the neural tube.
Cell counts in the somites were done manually from a z-stack of
the whole somite. For each set of experiments, cells were counted
and imaged at the first four somites of the yolk extension, unless
stated otherwise. For quantification of Pax3/7+ pre-myogenic
progenitor cells, only weakly labeled Pax3/7+ nuclei were counted
as previously described [38]. Digital pictures of WISH embryos
were obtained using the Zeiss Axioplan Stereomicroscope
(comparable available microscope is Zeiss Axio Imager) equipped
with a Leica digital camera and were adjusted for brightness and
contrast using Adobe Photoshop 7.0.
Western blot and quantification
Embryos (54 hpf) were dechorionated, deyolked in deyolking
buffer (5 mM KCl, 10 mM D-glucose in PBS), and lysed by
sonification for 15 seconds in 50 mM Tris pH 7.5, 150 mM NaCl,
1 mM EDTA, 1% NP-40, 0.1% sodium deoxyocholate and
protease inhibitor cocktail (Complete mini, Roche). An equivalent
of 12 embryos per lane was fractionated by 17.5% SDS-PAGE gel
and blotted semi-dry to PVDF membrane (Millipore). Membranes
were stained with Coomassie blue stain to verify loading.
Membranes were blocked in blockbuffer (50 mM Tris-HCL,
150 mM NaCl, 0.25% gelatin, 0.5% Triton X-100, pH 7.4) and
incubated overnight at 4uC with rabbit anti-Myostatin antibody
(AB3239, Millipore, 1:2500), washed 3610 min with 100 mM
Tris HCl pH 7.5, 0.1% Tween-20 and incubated for 1 h at RT
with secondary horseradish peroxidase conjugated anti-rabbit IgG
antibody (#554021, BD Transduction Laboratories, 1:10000),
followed by enhanced chemiluminescence (Sigma Aldrich). For
actin-loading control, membrane was stripped in 62.5 mM Tris
HCl pH 6.8, 2% SDS, 0,14% b-mercaptoethanol, blocked in
TBS-0.05% Tween +5% milk and incubated with rabbit anti-actin
antibody (A5060, Sigma Aldrich, 1/5000) in TBS-0.05% Tween
+2% milk overnight at 4uC, followed by HRP-conjugated anti-
rabbit IgG antibody in TBS-0.05% Tween for 1 h at RT, and
developed by enhanced chemiluminescence. The film was scanned
with GS-800 Calibrated Densitometer (BioRad) and quantitated
with Quantity One 4.6.7 program.
Lithium chloride treatment
LiCl treatment (0.3 M) was repeated twice on the same clutch of
embryos for each of the 3 developmental intervals: (1) Early: LiCl
treatment pulse for 40 minutes at tailbud and again at 16 hpf, (2)
Mid: LiCl treatment pulse for 40 minutes at 16 hpf and again at
24 hpf, and (3) Late: LiCl treatment pulse at 24 hpf and again at
30 hpf. Embryos were washed 3 times in between treatments.
Upon treatments, embryos were fixed at 36 hpf, and stained with
Phalloidin to visualize all muscle fibers.
HUA treatment
Embryos were cultured in both 75 mM aphidicolin with 0.25%
DMSO (Sigma-Aldrich) and 20 mM hydroxyurea (Sigma-Aldrich)
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experiments.
BrdU labeling
For BrdU labeling experiments, embryos (16 hpf, 28 hpf,
36 hpf) were dechorionated and placed in 10 mM BrdU with
15% DMSO on ice for 1 hour. After pulsing, embryos were
washed in embryo medium several times and incubated at 28uC
for 12 hours. Embryos were then fixed with 4% PFA and
immunohistochemistry was performed as above, with incubation
in 2 N HCl for 1 hour prior to blocking.
RNA isolation and qRT-PCR
For experiments in Figure 2B, total RNA was isolated from
36 hpf (n=40) or 54 hpf (n=40) wild-type and 36 hpf axin1/apc1
(n=40) or 54 hpf (n=40) axin1/apc1 embryos. DDCT of wild-type
was set as 1 for both 36 hpf and 54 hpf, and corresponding values
for axin1/apc1 36 hpf and axin1/apc1 54 hpf were normalized to
this wild-type. For experiments in Figure 7B and C, embryos were
injected with 2 ng Lef1-MO. At 36 hpf, 40 of each wild-type,
axin1/apc1 homozygous and lef1-MO injected embryos were
collected. Total RNA extraction and purification was performed
using standard Trizol and isopropanol precipitation. cDNA
synthesis was performed using hexamers and M-MLV Reverse
Transcriptase. Concentration of purified cDNA was measured
with Nanodrop. 50 ng cDNA was used for each set of primers.
Transcript levels of myhz2, myhz5, actin and mstn were quantified by
real-time PCR using iQ
TM SYBRH Green Supermix (Bio-Rad) on
an iCycler iQ Real-Time PCR Detection System (Bio-Rad).
Results were expressed as a relative ratio to the housekeeping gene
actin according to a mathematical method as described [55].
Primer sequences are as follows: mstn(F) 59-GATTAACGCA-
TATGACGCGAAG-39, mstn(R) 59-ACAGTGAGAGGG-
TACCTGCAG-39, myhz2(F) 59-ACAGTTTTTCAACCACCA-
CATGTT-39, myhz2(R) 59- AATGCAAGCGGCCAAGTC-39,
myhz5(F) 59- GCTGGAGAATGAGGTGGAGTTG-39,
myhz5(R) 59- AGTCTGGTAGGTGAGCTCCTTGA-39, Actin-
Control(F) 59-CAACAGGGAAAAGATGACACAGAT-39, Ac-
tinControl(R) 59-CAGCCTGGATGGCAACGT-39. Accession
numbers for mstn is NM_131019, myhz2 is NM_152982, myhz5 is
AY333451 and actin is AF025305. Triplicates were carried out for
each amplification.
Statistical analysis
Shapiro-Wilk normality test was performed with SPSS 16.0. All
data followed normal distribution, with the exception of wild-type
DMSO controls in Fig. 3d. Unpaired two-tailed student’s t-test
was performed using SPSS 16.0. For wild-type DMSO controls in
Fig. 3d, where no normal distribution was observed, non-
parametric Mann-Whitney test was used. All significant differences
(p,0.05) are marked with an asterisk (*) and highly significant
differences (p,0.005) are marked with two asterisks (**). All bars
in graphs depict mean values with error bars depicting standard
deviations.
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